{"url_path":"/fda/device/recalls/Z-3093-2026","section_key":"summary","section_title":"DEVICE Recall: Fresenius Medical Care Renal Therapies Group, LLC — Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis:  Product Numbers:  08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis","topic":"fda","document":{"doc_type":"device-recall","doc_date":"2026-07-14","source_url":"https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3093-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Fresenius Medical Care Renal Therapies Group, LLC"},"word_count":93,"has_tables":false,"body_markdown":"# FDA DEVICE Recall: Z-3093-2026\n\n**Recalling firm:** Fresenius Medical Care Renal Therapies Group, LLC\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-07-14\n**Report date:** 2026-09-09\n\n## Product\nCitrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis:  Product Numbers:  08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis\n\n## Reason\nComplaints of blue-green discoloration in product\n\n## Affected lots\n1) 08-2251-CA, UDI/DI 00840861101344, Lot Numbers:  26BXAC038;  2) 08-3251-CA, UDI/DI 00840861101351, Lot Numbers:  26BXAC039;  3) 13-2251-CA, UDI/DI 00840861101375, Lot Numbers:  26BXAC040, 26BXAC041.\n\n## Distribution\nWorldwide distribution - US Nationwide and the country of Mexico."}